During the past decade, USC Westside Center for Diabetes conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "USC Westside Center for Diabetes" #1 collaborator was "Pendulum Therapeutics" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "USC Westside Center for Diabetes" are "Diabetes Mellitus, Type 1" (1 trials), "Gastrointestinal Symptoms" (1 trials), "Hypoglycemia" (1 trials) and "Type2 Diabetes" (1 trials). Many other conditions were trialed in "USC Westside Center for Diabetes" in a lesser frequency.

Most popular intervention types in "USC Westside Center for Diabetes" are "Dietary Supplement" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "CGM-Tele-monitoring" (1 trials) and "Pendulum Glucose Control formulation for T2D" (1 trials). Other intervention names were less common.

The vast majority of trials in "USC Westside Center for Diabetes" are 2 trials for "All" genders.

Currently, there are NaN active trials in "USC Westside Center for Diabetes". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in USC Westside Center for Diabetes, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in USC Westside Center for Diabetes, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".